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INFORMATION FOR AUTHORS
Fundamental and Applied Toxicology, an official publication of the Society of Toxicology, publishes scientific articles and reports relating to those broad aspects of toxicology which are relevant to assessing the risk or effects of toxic agents (chemicals, including drugs and natural products or forms of energy) on human and other animal health. Examples include statistical and mathematical methods of risk assessment and safety evaluation studies which are structural, biochemical, or functional in nature. Fundamental and Applied Toxicology also will consider manuscripts that are concerned with methods or systems of evaluation of toxicity as an alternative to the use of experimental animals.
Also included are articles on methods and equipment, regulatory issues or policy articles relevant to the practice of toxicology, scientific reviews on specific topics, and articles from symposia. Special sections will cover Meetings, Book Reviews, and Letters to the Editor.
Manuscripts are accepted for review with the understanding that the same work has not been published, that it is not under consideration for publication elsewhere, and that its submission for publication has been approved by all of the authors and by the institution where the work was carried out; further that any person cited as a source of personal communications has approved such citation.
Authors submitting a manuscript do so on the understanding that if it is accepted for publication, copyright in the article, including the right to reproduce the article in all forms and media, shall be assigned exclusively to the Society. The Society will not refuse any reasonable request by the author for permission to reproduce any of his or her contributions to the journal.
Manuscript handling fee. The Society of Toxicology has established that a manuscript handling fee of $100.00, payable to the Society of Toxicology in United States currency, must accompany the original submission of the manuscript. The name(s) of the authors) and the title of the manuscript must be included in the check identification information. In the event that this fee cannot be met by the authors or their institution, an explanatory letter must be sent to the Editor with the manuscript. The editorial decision regarding eventual acceptance or rejection of the manuscript will be independent of the submission of the manuscript handling fee. Form of manuscript. Four complete copies of each manuscript, in English, should be submitted. All manuscripts must be typewritten, double-spaced (including references) on one side of 8.5 X 11-in. white paper with 1-in. margins on all sides.
Submission of manuscripts. All manuscripts (four copies) should be submitted to:
Fundamental and Applied Toxicology
Page 1 should contain the article title, the names and affiliations of all authors, an abbreviated form of the title (not to exceed 40 characters including letters and spaces), and the name and complete mailing address (and telephone number if possible) of the person to whom all correspondence should be sent. The article title should be comprehensive and descriptive: proprietary names must not be used in titles, but may be identified in footnotes.
Page 2 should contain an abstract starting with the title of the paper, followed by the authors' names and reference to Fundamental and Applied Toxicology; blanks should be left so that the Editor may fill in the volume and page numbers. The abstract will be limited to 250 words but must contain a concise summary of what was done, the results obtained, and valid conclusions which are drawn therefrom. It must mention the compounds or families of compounds studied, their actions, and the species of animals. It must contain important words which are used as index terms, but not proprietary names. Introduction. State why the investigation was carried out, note any relevant published work, and delineate the objective of the investigation.
Example: Early Effects of Lead on
Methods. New methods or significant improvements of methods or changes in old methods must be described. Methods for which adequate reference can be cited are not to be described. In the Methods section, authors should draw attention to any particular chemical or biological hazards that may be involved in carrying out the experiments described. Any relevant safety precautions should be described; if an accepted code of practice has been followed, a reference to the relevant standards should be given.
Results. Duplication between the text of this section and material presented in tables and figures should be avoided. Tabular presentation of masses of negative data must be avoided and replaced with a statement in the text whenever possible. The statement must include (a) what was done, (b) how it was done, (c) how the data were analyzed, (d) a measure of variability, and (e) the significance of the result.
Discussion. This section must relate to the significance of the work to existing knowledge in the field and indicate the importance of the contribution of this study. Needless detailed recapitulation of the results must be avoided. Unsupported hypotheses and speculation should be omitted.
References. Names of authors are to be cited in the text with the year of publication in parentheses. When there are more than two authors use the first author's name followed by el al. All papers mentioned in the text must be listed in the reference list and vice versa. References should be listed alphabetically typed doublespaced on a separate sheet at the end of the paper with all authors included. Journal titles should be abbreviated according to Chemical Abstracts Service Source Index, 1985. Note the following styles for references. Coulston, F., and Pocchiari, F. (1983 Footnotes should be identified in the text by superscript Arabic numerals and cited consecutively throughout the paper. All footnotes should be listed in order and typed double-spaced on a separate sheet. Proprietary names of substances and names and addresses of suppliers should be identified in footnotes. If the paper has been presented orally in whole or in part, the date and occasion should be included in a footnote.
Tables must be typed double-spaced on a separate sheet with the title typed directly above the table. Do not use abbreviations in the title. The title and footnotes must contain all the information necessary to understand and interpret the table without reference to the text. Tables must be numbered consecutively with Arabic numerals. Footnotes to tables should be identified by superscript lowercase italic letters and placed at the bottom of the page containing the table. Letters should be assigned to table footnotes alphabetically in order of appearance as the table is read horizontally, not vertically.
Figures should be numbered consecutively with Arabic numerals. All legends are to be typed consecutively on a separate sheet. All figures should be planned to fit the proportions of the printed page (7^X9 in.; column width, 3.5 in.); wherever possible, figures will be reduced to single-column width. Lettering on the original figure should be of professional quality or generated by high-resolution computer graphics and should be large enough (10-12 points) to be legible after reduction of the figure to single-column width (approximately 50 to 60%). Differences in type size within a single figure should be no more than approximately 15%. Freehand, penciled, or typewritten lettering is not acceptable. Drawings should be made with the equivalent of black India ink on tracing linen, smooth-surface white paper, or Bristol board. Alternatively, highquality computer graphics may be acceptable. In addition, symbols used to identify points within a graph should be large enough that they will be easily distinguishable after reduction. Graphs should be plotted with black India ink on blue coordinate or white paper no larger than 8.5 X 11 in. Grid lines that are to show must be inked in black.
Photographs must be kept to a minimum. Photographs should be glossy prints (5 X 7 or 8 X 10 in.). High-contrast micrographs should be submitted in quadruplicate. Overlays indicating the parts of the electron micrographs that are to be emphasized must be used. Electron micrographs should be submitted not larger than 6.5 X 4.5 in. Magnification should be indicated by a bar on the photograph.
Illustrations in color will be accepted only if the authors defray the cost.
Index terms suitable for use in the subject index must be submitted on a separate sheet. The list should include chemical name, generic name, and common name, and may include the proprietary name of each important substance used in the experiments. It should also include biological activity of each substance investigated. Terms should elucidate important relationships.
Nomenclature. For styling of isotope, enzyme, and biochemical nomenclature, consult the extended Instructions to Authors published in each January issue of Archives of Biochemistry and Biophysics.
Abbreviations. Units will be in general accordance with the International System (SI) as adopted by the 1 lth General Conference on Weights and Measures. Periods are notused after abbreviations (note exceptions, e.g., in. for inches). Reprints. A reprint order form will accompany the proofs. Fifty reprints of each article (without covers) are supplied free of charge. Authors may purchase additional reprints using the form provided.
Communications (Preliminary Reports). Fundamental and
Applied Toxicology will accept a limited number of brief reports of work that has progressed to the stage at which it is considered that the science of toxicology would be advanced if the results were made available as soon as possible. These reports will be designated "Preliminary Reports." Authors should submit short papers for this category of publication only when they believe that the rapid communication of the results is of the utmost importance to other investigators. Four copies of the manuscript, with a letter requesting publication as a Preliminary Report, must be submitted and conform strictly to the form and style of the journal. The length must be such that it will require no more than two pages in the present format of the journal.
Letters to the Editor. Letters to the Editor will be accepted for publication subject to Editorial Board approval, provided that the content deals with papers published in Fundamental and Applied Toxicology and that the comments are of scientific value. Letters should be received within two months of mailing of the journal and should be no longer than 250 words. Introduction of new data will not be permitted. Each letter will be submitted to the author of the original paper in order that any reply may be published simultaneously with the letter. Stratagene has developed a line of inbred C57BI6 transgenic mice for mutation analysis in vivo. Lambda phage shuttle vectors containing a Lacl q target gene have been integrated into the genome of each mouse. After delivery of a test compound to the mouse, the lambda phage vectors containing the target gene can be quickly and easily recovered from isolated genomic DNA using Transpack™ in vitro packaging extract. Mutations in the target gene are detected by infecting host E. co//with the rescued phage and plating in the presence of the chromogenic substrate X-gal. Blue plaques are formed by mutations in the target Lad" gene, while intact LacP genes result in clear plaques. The mutant frequency of the test compound is determined by counting the number of easy to read blue plaques versus colorless plaques.
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The Big Blue™ mouse mutagenesis assay system*-the only complete short term, whole animal mutagenesis system available. With our system you can:
• Identify and quantitatively measure the potential mutagenicity of test compounds • Readily identify mutations • Obtain results 3 days after exposure to a test compound • Study the effects of different routes of administration of a test compound on mutagenicity • Analyze target organ susceptibility to mutagenesis • Assess germ cell mutagenicity • Easily characterize mutations by sequence analysis The Big Blue™ mouse mutagenesis assay system includes everything you need to complete an in vivo mutagenesis study. Stratagene will teach you how to use this system in workshops at our corporate headquarters in La Jolla, California. Please call us regarding the licensing of this proprietary technology and bring this system into your laboratory today! 
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